<DOC>
	<DOCNO>NCT02415842</DOCNO>
	<brief_summary>The purpose exploratory , retrospective laboratory study assess humoral immune response H1 hemagglutinin stalk domain influenza A virus protein epitopes follow administration , adult child , GSK Biologicals ' adjuvanted unadjuvanted pandemic influenza vaccine , use archive serum sample previously complete clinical trial .</brief_summary>
	<brief_title>A Laboratory Evaluation Humoral Immune Response Adults Children H1 Hemagglutinin ( HA ) Stalk Domain Other Influenza A Virus Protein Epitopes , After Administration GlaxoSmithKline ( GSK ) Biologicals ' Pandemic Influenza Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Hemagglutinins</mesh_term>
	<criteria>Not applicable since subject actively enrol study ; serum sample subject part previously conduct primary trial use test . However , archive serum sample subject satisfy follow criterion include study : Subjects receive two dos influenza vaccine 21 day apart include ATP cohort immunogenicity Persistence cohort ( depend study ) primary study list . Subjects agree blood sample could use research give informed consent primary study list . Subjects sufficient residual sample volume ( i.e. , â‰¥0.5 mL ) serum time point . Subjects vaccine homologous neutralize antibody result available Day 0 21 ( 25 sample available per group Study H9N2001 ) Not applicable since subject actively enrol study ; serum sample subject part previously conduct trial use test .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Supra-seasonal influenza vaccine</keyword>
	<keyword>Pandemic</keyword>
	<keyword>Exploratory</keyword>
	<keyword>Protein epitope</keyword>
	<keyword>Laboratory evaluation</keyword>
	<keyword>Retrospective</keyword>
</DOC>